Cargando…
2893 B. Effect of Cefepime versus Piperacillin-Tazobactam in Adults Hospitalized with Acute Infection: A Randomized Clinical Trial
BACKGROUND: Cefepime and piperacillin-tazobactam are commonly administered to hospitalized adults for empiric treatment of infection. Although piperacillin-tazobactam has been hypothesized to cause acute kidney injury and cefepime has been hypothesized to cause neurological dysfunction, their compar...
Autores principales: | Qian, Edward, Casey, Jonathan, Wright, Adam, Wang, Li, Shotwell, Matthew, Siemann, Justin, Dear, Mary Lynn, Stollings, Joanna, Lloyd, Bradley, Marvi, Tanya, Seitz, Kevin, Nelson, George E, Wright, Patty W, Siew, Edward, Dennis, Bradley, Wrenn, Jesse, Andereck, Jonathan, Han, Jin, Self, Wesley H, Semler, Matthew, Rice, Todd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678647/ http://dx.doi.org/10.1093/ofid/ofad500.2477 |
Ejemplares similares
-
Protocol and statistical analysis plan for the Antibiotic Choice On ReNal outcomes (ACORN) randomised clinical trial
por: Qian, Edward Tang, et al.
Publicado: (2023) -
Piperacillin-Tazobactam Versus Anti-Pseudomonal Cephalosporins and Renal and Neurologic Outcomes in Critically Ill Adults: A Secondary Analysis of the SMART Trial
por: Qian, Edward T., et al.
Publicado: (2023) -
A Comparison Between Cefepime and Piperacillin-Tazobactam in the Management of Septic Shock
por: Ross, Robert C, et al.
Publicado: (2021) -
Comparison of Cefepime with Piperacillin/Tazobactam Treatment in Patients with Hospital-Acquired Pneumonia
por: Kim, Bo-Guen, et al.
Publicado: (2023) -
726. Risk factor analysis for cefepime and piperacillin/tazobactam resistant organisms
por: Pham, Tho H, et al.
Publicado: (2023)